pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
regdanvimab
regdanvimab [INN]
Coronavirus Disease 2019 (COVID-19)
Celltrion Inc
0 catalysts
Marketed
regorafenib
Stivarga (regorafenib)
Recurrent Glioblastoma Multiforme (GBM)
Discoidin domain-containing receptor 2Ephrin type-A receptor 2
Bayer AG
0 catalysts
Marketed
relacorilant
Lifyorli (relacorilant)
Epithelial Ovarian Cancer
CORCEPT THERAPEUTICS INC
← prev
page 212 of 231
next →
131
Pain89
Neurology1
$CORT
0 catalysts
Phase 2
relatlimab
Metastatic Hepatocellular Carcinoma (HCC)
Lymphocyte activation gene 3 protein
Bristol-Myers Squibb Co
0 catalysts
pre_registration
relutrigine
relutrigine [INN]
Epileptic Encephalopathy
$PRAXPraxis Precision Medicines, Inc.
0 catalysts
Phase 3
remestemcel-L
Prochymal (remestemcel-L)
Crohn's Disease (Regional Enteritis)
$MESOMESOBLAST LTD
0 catalysts
Phase 2
remetinostat
Cutaneous T-Cell Lymphoma
Biossil Inc
0 catalysts
Marketed
remimazolam besylate
Byfavo (remimazolam besylate)
Sedation
GABA-A receptor; anion channel
Acacia Pharma Group Ltd
0 catalysts
Phase 3
remlifanserin
Alzheimer's Disease
$ACADACADIA PHARMACEUTICALS INC
0 catalysts
Phase 1
remzistotug
Breast Cancer
$GSKGSK plc
0 catalysts
Phase 2
rencofilstat
Hepatocellular Carcinoma
$HEPAHepion Pharmaceuticals, Inc.
0 catalysts
Phase 2
rentosertib acetate
Idiopathic Pulmonary Fibrosis
InSilico Medicine
0 catalysts
Marketed
repaglinide
Repaglinide (repaglinide)
Type 2 Diabetes
Padagis LLC
0 catalysts
Phase 3
repinatrabit
Phenylketonuria (PKU)
Jnana Therapeutics Inc
0 catalysts
Preclinical
repirinast
Chronic Kidney Disease (Chronic Renal Failure)
$AGNPFAlgernon Health Inc.
0 catalysts
Marketed
repotrectinib
Augtyro (repotrectinib)
Non-Small Cell Lung Cancer
NT-3 growth factor receptorBDNF/NT-3 growth factors receptor
Bristol-Myers Squibb Co
0 catalysts
Phase 3
resecabtagene autoleucel
resecabtagene autoleucel [INN]
Juvenile Dermatomyositis
$CABACabaletta Bio, Inc.
0 catalysts
Phase 3
resiniferatoxin
resiniferatoxin [INN]
Osteoarthritis Pain
Grunenthal GmbH
0 catalysts
Phase 2
resiquimod
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Toll-like receptor 7Toll-like receptor 8
SURGE Therapeutics Inc
0 catalysts
Phase 2
resiquimod sulfate
Squamous Non-Small Cell Lung Cancer
$EIKNEikon Therapeutics, Inc.
0 catalysts
Marketed
reslizumab
Cinqair (reslizumab)
Eosinophilic Asthma
Teva Pharmaceuticals USA Inc
0 catalysts
Phase 2
resomelagon acetate
Rheumatoid Arthritis
SynAct Pharma AB
0 catalysts
Phase 2
respiratory syncytial virus vaccine
mRESVIA
Respiratory Syncytial Virus (RSV) Infections
Fusion glycoprotein F0
$MRNAModerna, Inc.
0 catalysts
Marketed
reteplase
Retavase (reteplase)
Congestive Heart Failure (Heart Failure)
Chiesi USA Inc
0 catalysts
Phase 3
retogatein
Diamyd (retogatein)
Type 1 Diabetes (Juvenile Diabetes)
Diamyd Medical AB
0 catalysts
Marketed
revakinagene taroretcel
Encelto (revakinagene taroretcel-iwey)
Idiopathic Juxtafoveolar Retinal Telangiectasis (IJRT)
Neurotech Pharmaceuticals Inc
0 catalysts
Marketed
revefenacin
Yupelri (revefenacin)
Chronic Obstructive Pulmonary Disease (COPD)
Theravance Biopharma US Inc
0 catalysts
Phase 3
rexlemestrocel-L
Revascor (rexlemestrocel-L)
Hypoplastic Left Heart Syndrome
$MESOMESOBLAST LTD
0 catalysts
Phase 2
rezatapopt
Bile Duct Cancer (Cholangiocarcinoma)
$PMVPPMV Pharmaceuticals, Inc.
0 catalysts
Phase 2
rezpegaldesleukin
Alopecia Areata
$NKTRNEKTAR THERAPEUTICS
0 catalysts